BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1533519)

  • 1. Distinct mechanisms of inhibition of purified cardiac sarcolemma Ca(2+)-ATPase by two calmodulin antagonists.
    Pasa TC; Otero A; Barrabin H; Scofano HM
    Biochem Pharmacol; 1992 Apr; 43(8):1797-803. PubMed ID: 1533519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the calmodulin antagonists compound 48/80 and calmidazolium.
    Gietzen K
    Biochem J; 1983 Dec; 216(3):611-6. PubMed ID: 6141789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel effects of calmodulin and calmodulin antagonists on the plasma membrane (Ca2+ + Mg2+)-ATPase from rabbit kidney proximal tubules.
    Coelho-Sampaio T; Teixeira-Ferreira A; Vieyra A
    J Biol Chem; 1991 Jun; 266(16):10249-53. PubMed ID: 1828069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Ca2+-dependent protein kinase and Ca2+/Mg2+-ATPase in cardiac sarcolemma by the anti-calmodulin drug calmidazolium.
    Lamers JM; Stinis JT
    Cell Calcium; 1983 Oct; 4(4):281-94. PubMed ID: 6139171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study to see whether phosphatidylserine, partial proteolysis and EGTA substitute for calmodulin during activation of the Ca2+-ATPase from red cell membranes by ATP.
    Rossi JP; Rega AF
    Biochim Biophys Acta; 1989 Jul; 996(3):153-9. PubMed ID: 2526658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities between the effects of dimethyl sulfoxide and calmodulin on the red blood cell Ca2(+)-ATPase.
    Benaim G; de Meis L
    Biochim Biophys Acta; 1990 Jul; 1026(1):87-92. PubMed ID: 2143083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of felodipine and bepridil on calcium-stimulated calmodulin binding and calcium pumping ATPase of cardiac sarcolemma before and after removal of endogenous calmodulin.
    Lamers JM; Verdouw PD; Mas-Oliva J
    Mol Cell Biochem; 1987 Dec; 78(2):169-76. PubMed ID: 2964559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the nucleotide dependence of the cardiac sarcolemma Ca(2+)-ATPase.
    Pasa TC; Otero AS; Barrabin H; Scofano HM
    J Mol Cell Cardiol; 1992 Mar; 24(3):233-42. PubMed ID: 1385633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmidazolium and compound 48/80 inhibit calmodulin-dependent protein phosphorylation and ATP-dependent Ca2+ uptake but not Ca2+-ATPase activity in skeletal muscle sarcoplasmic reticulum.
    Tuana BS; MacLennan DH
    J Biol Chem; 1984 Jun; 259(11):6979-83. PubMed ID: 6233277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The so-called anticalmodulins fluphenazine, calmidazolium, and compound 48/80 inhibit the Ca2+- transport system of the endoplasmic reticulum.
    Wülfroth P; Petzelt C
    Cell Calcium; 1985 Aug; 6(4):295-310. PubMed ID: 2931173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM; Cysouw KJ; Verdouw PD
    Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of basal and calmodulin-activated Ca2+-pump ATPase by fractionated compound 48/80.
    Di Julio D; Hinds TR; Vincenzi FF
    Biochim Biophys Acta; 1989 Jun; 981(2):337-42. PubMed ID: 2525052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound 48/80 is a selective and powerful inhibitor of calmodulin-regulated functions.
    Gietzen K; Adamczyk-Engelmann P; Wüthrich A; Konstantinova A; Bader H
    Biochim Biophys Acta; 1983 Dec; 736(1):109-18. PubMed ID: 6317027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound 48/80 and calmodulin modify the interaction of ATP with the (Ca2+ + Mg2+)-ATPase of red cell membranes.
    Rossi JP; Rega AF; Garrahan PJ
    Biochim Biophys Acta; 1985 Jun; 816(2):379-86. PubMed ID: 3159427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further characterization and reconstitution of the purified Ca2+-pumping ATPase of heart sarcolemma.
    Caroni P; Zurini M; Clark A; Carafoli E
    J Biol Chem; 1983 Jun; 258(12):7305-10. PubMed ID: 6223026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some properties of the purified (Ca2+ + Mg2+)-ATPase from human red cell membranes.
    Stieger J; Luterbacher S
    Biochim Biophys Acta; 1981 Feb; 641(1):270-5. PubMed ID: 6111343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the erythrocyte Ca(2+)-ATPase at high pH.
    de Carvalho-Alves PC; Freire MM; Barrabin H; Scofano HM
    Eur J Biochem; 1994 Mar; 220(3):1029-36. PubMed ID: 8143719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of skeletal muscle sarcoplasmic reticulum CaATPase activity by calmidazolium.
    Anderson KW; Coll RJ; Murphy AJ
    J Biol Chem; 1984 Sep; 259(18):11487-90. PubMed ID: 6236226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of berbamine derivatives on activated Ca2+-stimulated Mg2+-dependent ATPase in erythrocyte membranes.
    Xu YH; Liu J; Zhang SP; Liu LH
    Biochem J; 1987 Dec; 248(3):985-8. PubMed ID: 2963623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of compound 48/80 on the ATPase and phosphatase activities of the Ca2+ pump of red cells.
    Rossi JP; Garrahan PJ; Rega AF
    Biochim Biophys Acta; 1987 Aug; 902(1):101-8. PubMed ID: 3038189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.